NTRK1 and cancer: The intent of this review is to present basic genetic concepts key to understanding oncogenesis and the role tyrosine kinase inhibition plays in the targeted treatment of many cancer types.4 In particular, the focus will be on the drugs that inhibit the activity of receptor tyrosine kinases (RTKs) that are transmembrane signaling receptors located on the surface of cells.